AGREEMENT BY AND BETWEEN REGEN SYBLEU INC. ( SYBE) AND ZANDER BIOLOGICS, INC.(ZAND). (“Agreement”) SYBE and ZAND may be referred to in this Agreement each as a “Party” or collectively as the “Parties.” This Agreement is dated June 30, 2023Purchase Agreement • July 7th, 2023 • SYBLEU Inc • Pharmaceutical preparations
WHEREAS ZAND holds all right, title and interest in and to including, but not limited to, the copyrights, trade secrets, trademarks and associated good will and patent rights to the intellectual property described in Exhibit A. (“IP Rights”)
